Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mild cognitive impairment: imaging data].

J Touchon1, F Portet

  • 1Unité de Neurologie Comportementale et Dégénérative, Neurologie B, CHU Gui-de-Chauliac, 34295 Montpellier Cedex 05 INSERM E 99-30, CHU de Montpellier.

Revue Neurologique
|January 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanolithium, a New Treatment Approach to Alzheimer's Disease: A Review of Existing Evidence and Clinical Perspectives.

The journal of prevention of Alzheimer's disease·2024
Same author

Editorial: What Is Reasonable and Necessary for Alzheimer Patients from Randomized Clinical Trials to Clinical Practice?

The journal of prevention of Alzheimer's disease·2023
Same author

The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force Report.

The journal of prevention of Alzheimer's disease·2022
Same author

Can We Distinguish Age-Related Frailty from Frailty Related to Diseases ? Data from the MAPT Study.

The journal of nutrition, health & aging·2020
Same author

Non-Amyloid Approaches to Disease Modification for Alzheimer's Disease: An EU/US CTAD Task Force Report.

The journal of prevention of Alzheimer's disease·2020
Same author

Anti-Tau Trials for Alzheimer's Disease: A Report from the EU/US/CTAD Task Force.

The journal of prevention of Alzheimer's disease·2019
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
Same journal

Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families.

Revue neurologique·2026
See all related articles

Diagnosing Mild Cognitive Impairment (MCI) can be improved with advanced brain imaging techniques. These methods help differentiate MCI subtypes and identify early Alzheimer's disease (AD) signs.

Area of Science:

  • Neurology
  • Radiology
  • Neuroscience

Background:

  • Mild Cognitive Impairment (MCI) diagnosis currently relies solely on clinical observations.
  • Identifying subtypes of MCI and prodromal Alzheimer's Disease (AD) remains a challenge.

Purpose of the Study:

  • To explore the diagnostic utility of cerebral imaging in Mild Cognitive Impairment.
  • To assess the potential of various imaging modalities for differentiating MCI subtypes and detecting prodromal AD.

Main Methods:

  • Volumetric Magnetic Resonance Imagery (MRI) to examine brain structures like the hippocampus and entorhinal cortex.
  • Functional imaging techniques including Positron Emission Tomography (PET) and single-photon emission computed tomography (SPECT) to assess regional brain activity.
  • Investigating the role of functional MRI (fMRI) with cognitive activation paradigms.

Related Experiment Videos

Main Results:

  • Volumetric MRI is valuable for assessing structures vulnerable to early AD pathology.
  • Hypoactivity in specific brain regions (temporal lobe, posterior cingulate gyrus) detected by PET and SPECT shows diagnostic potential.
  • Functional imaging of the cholinergic system may offer future diagnostic value for MCI-AD.

Conclusions:

  • Cerebral imaging, particularly MRI, significantly aids MCI diagnosis and subtyping.
  • Functional MRI combined with cognitive activation paradigms shows considerable promise for future diagnostic applications in MCI-AD.